United States Allergy Immunotherapies Market Report 2017

December 2017 | 102 pages | ID: U69A6CE41B3EN
QYResearch

Abstracts

In this report, the United States Allergy Immunotherapies market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Allergy Immunotherapies in these regions, from 2012 to 2022 (forecast).

United States Allergy Immunotherapies market competition by top manufacturers/players, with Allergy Immunotherapies sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• ALK Abello
• Allergy Therapeutics
• Circassia
• DBV Technologies
• Stallergenes Greer
• Merck KGaA (Allergopharma)
• HAL Allergy Group (Netherlands)

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Subcutaneous Immunotherapy
• Sublingual Immunotherapy

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Allergic Rhinitis
• Allergic Asthma
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Allergy Immunotherapies Market Report 2017

1 ALLERGY IMMUNOTHERAPIES OVERVIEW

1.1 Product Overview and Scope of Allergy Immunotherapies
1.2 Classification of Allergy Immunotherapies by Product Category
  1.2.1 United States Allergy Immunotherapies Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Allergy Immunotherapies Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Subcutaneous Immunotherapy
  1.2.4 Sublingual Immunotherapy
1.3 United States Allergy Immunotherapies Market by Application/End Users
  1.3.1 United States Allergy Immunotherapies Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Allergic Rhinitis
  1.3.3 Allergic Asthma
  1.3.4 Other
1.4 United States Allergy Immunotherapies Market by Region
  1.4.1 United States Allergy Immunotherapies Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Allergy Immunotherapies Status and Prospect (2012-2022)
  1.4.3 Southwest Allergy Immunotherapies Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Allergy Immunotherapies Status and Prospect (2012-2022)
  1.4.5 New England Allergy Immunotherapies Status and Prospect (2012-2022)
  1.4.6 The South Allergy Immunotherapies Status and Prospect (2012-2022)
  1.4.7 The Midwest Allergy Immunotherapies Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Allergy Immunotherapies (2012-2022)
  1.5.1 United States Allergy Immunotherapies Sales and Growth Rate (2012-2022)
  1.5.2 United States Allergy Immunotherapies Revenue and Growth Rate (2012-2022)

2 UNITED STATES ALLERGY IMMUNOTHERAPIES MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Allergy Immunotherapies Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Allergy Immunotherapies Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Allergy Immunotherapies Average Price by Players/Suppliers (2012-2017)
2.4 United States Allergy Immunotherapies Market Competitive Situation and Trends
  2.4.1 United States Allergy Immunotherapies Market Concentration Rate
  2.4.2 United States Allergy Immunotherapies Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Allergy Immunotherapies Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ALLERGY IMMUNOTHERAPIES SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Allergy Immunotherapies Sales and Market Share by Region (2012-2017)
3.2 United States Allergy Immunotherapies Revenue and Market Share by Region (2012-2017)
3.3 United States Allergy Immunotherapies Price by Region (2012-2017)

4 UNITED STATES ALLERGY IMMUNOTHERAPIES SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Allergy Immunotherapies Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Allergy Immunotherapies Revenue and Market Share by Type (2012-2017)
4.3 United States Allergy Immunotherapies Price by Type (2012-2017)
4.4 United States Allergy Immunotherapies Sales Growth Rate by Type (2012-2017)

5 UNITED STATES ALLERGY IMMUNOTHERAPIES SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Allergy Immunotherapies Sales and Market Share by Application (2012-2017)
5.2 United States Allergy Immunotherapies Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES ALLERGY IMMUNOTHERAPIES PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 ALK Abello
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Allergy Immunotherapies Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 ALK Abello Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Allergy Therapeutics
  6.2.2 Allergy Immunotherapies Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Allergy Therapeutics Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Circassia
  6.3.2 Allergy Immunotherapies Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Circassia Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 DBV Technologies
  6.4.2 Allergy Immunotherapies Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 DBV Technologies Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Stallergenes Greer
  6.5.2 Allergy Immunotherapies Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Stallergenes Greer Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Merck KGaA (Allergopharma)
  6.6.2 Allergy Immunotherapies Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Merck KGaA (Allergopharma) Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 HAL Allergy Group (Netherlands)
  6.7.2 Allergy Immunotherapies Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 HAL Allergy Group (Netherlands) Allergy Immunotherapies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview

7 ALLERGY IMMUNOTHERAPIES MANUFACTURING COST ANALYSIS

7.1 Allergy Immunotherapies Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Allergy Immunotherapies

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Allergy Immunotherapies Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Allergy Immunotherapies Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ALLERGY IMMUNOTHERAPIES MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Allergy Immunotherapies Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Allergy Immunotherapies Sales Volume Forecast by Type (2017-2022)
11.3 United States Allergy Immunotherapies Sales Volume Forecast by Application (2017-2022)
11.4 United States Allergy Immunotherapies Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Allergy Immunotherapies
Figure United States Allergy Immunotherapies Market Size (Units) by Type (2012-2022)
Figure United States Allergy Immunotherapies Sales Volume Market Share by Type (Product Category) in 2016
Figure Subcutaneous Immunotherapy Product Picture
Figure Sublingual Immunotherapy Product Picture
Figure United States Allergy Immunotherapies Market Size (Units) by Application (2012-2022)
Figure United States Sales Market Share of Allergy Immunotherapies by Application in 2016
Figure Allergic Rhinitis Examples
Table Key Downstream Customer in Allergic Rhinitis
Figure Allergic Asthma Examples
Table Key Downstream Customer in Allergic Asthma
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Allergy Immunotherapies Market Size (Million USD) by Region (2012-2022)
Figure The West Allergy Immunotherapies Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Allergy Immunotherapies Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Allergy Immunotherapies Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Allergy Immunotherapies Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Allergy Immunotherapies Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Allergy Immunotherapies Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Allergy Immunotherapies Sales (Units) and Growth Rate (2012-2022)
Figure United States Allergy Immunotherapies Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Allergy Immunotherapies Market Major Players Product Sales Volume (Units) (2012-2017)
Table United States Allergy Immunotherapies Sales (Units) of Key Players/Suppliers (2012-2017)
Table United States Allergy Immunotherapies Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Allergy Immunotherapies Sales Share by Players/Suppliers
Figure 2017 United States Allergy Immunotherapies Sales Share by Players/Suppliers
Figure United States Allergy Immunotherapies Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Allergy Immunotherapies Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Allergy Immunotherapies Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Allergy Immunotherapies Revenue Share by Players/Suppliers
Figure 2017 United States Allergy Immunotherapies Revenue Share by Players/Suppliers
Table United States Market Allergy Immunotherapies Average Price (K USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Allergy Immunotherapies Average Price (K USD/Unit) of Key Players/Suppliers in 2016
Figure United States Allergy Immunotherapies Market Share of Top 3 Players/Suppliers
Figure United States Allergy Immunotherapies Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Allergy Immunotherapies Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Allergy Immunotherapies Product Category
Table United States Allergy Immunotherapies Sales (Units) by Region (2012-2017)
Table United States Allergy Immunotherapies Sales Share by Region (2012-2017)
Figure United States Allergy Immunotherapies Sales Share by Region (2012-2017)
Figure United States Allergy Immunotherapies Sales Market Share by Region in 2016
Table United States Allergy Immunotherapies Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Allergy Immunotherapies Revenue Share by Region (2012-2017)
Figure United States Allergy Immunotherapies Revenue Market Share by Region (2012-2017)
Figure United States Allergy Immunotherapies Revenue Market Share by Region in 2016
Table United States Allergy Immunotherapies Price (K USD/Unit) by Region (2012-2017)
Table United States Allergy Immunotherapies Sales (Units) by Type (2012-2017)
Table United States Allergy Immunotherapies Sales Share by Type (2012-2017)
Figure United States Allergy Immunotherapies Sales Share by Type (2012-2017)
Figure United States Allergy Immunotherapies Sales Market Share by Type in 2016
Table United States Allergy Immunotherapies Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Allergy Immunotherapies Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Allergy Immunotherapies by Type (2012-2017)
Figure Revenue Market Share of Allergy Immunotherapies by Type in 2016
Table United States Allergy Immunotherapies Price (K USD/Unit) by Types (2012-2017)
Figure United States Allergy Immunotherapies Sales Growth Rate by Type (2012-2017)
Table United States Allergy Immunotherapies Sales (Units) by Application (2012-2017)
Table United States Allergy Immunotherapies Sales Market Share by Application (2012-2017)
Figure United States Allergy Immunotherapies Sales Market Share by Application (2012-2017)
Figure United States Allergy Immunotherapies Sales Market Share by Application in 2016
Table United States Allergy Immunotherapies Sales Growth Rate by Application (2012-2017)
Figure United States Allergy Immunotherapies Sales Growth Rate by Application (2012-2017)
Table ALK Abello Basic Information List
Table ALK Abello Allergy Immunotherapies Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure ALK Abello Allergy Immunotherapies Sales Growth Rate (2012-2017)
Figure ALK Abello Allergy Immunotherapies Sales Market Share in United States (2012-2017)
Figure ALK Abello Allergy Immunotherapies Revenue Market Share in United States (2012-2017)
Table Allergy Therapeutics Basic Information List
Table Allergy Therapeutics Allergy Immunotherapies Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Allergy Therapeutics Allergy Immunotherapies Sales Growth Rate (2012-2017)
Figure Allergy Therapeutics Allergy Immunotherapies Sales Market Share in United States (2012-2017)
Figure Allergy Therapeutics Allergy Immunotherapies Revenue Market Share in United States (2012-2017)
Table Circassia Basic Information List
Table Circassia Allergy Immunotherapies Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Circassia Allergy Immunotherapies Sales Growth Rate (2012-2017)
Figure Circassia Allergy Immunotherapies Sales Market Share in United States (2012-2017)
Figure Circassia Allergy Immunotherapies Revenue Market Share in United States (2012-2017)
Table DBV Technologies Basic Information List
Table DBV Technologies Allergy Immunotherapies Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure DBV Technologies Allergy Immunotherapies Sales Growth Rate (2012-2017)
Figure DBV Technologies Allergy Immunotherapies Sales Market Share in United States (2012-2017)
Figure DBV Technologies Allergy Immunotherapies Revenue Market Share in United States (2012-2017)
Table Stallergenes Greer Basic Information List
Table Stallergenes Greer Allergy Immunotherapies Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Stallergenes Greer Allergy Immunotherapies Sales Growth Rate (2012-2017)
Figure Stallergenes Greer Allergy Immunotherapies Sales Market Share in United States (2012-2017)
Figure Stallergenes Greer Allergy Immunotherapies Revenue Market Share in United States (2012-2017)
Table Merck KGaA (Allergopharma) Basic Information List
Table Merck KGaA (Allergopharma) Allergy Immunotherapies Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Merck KGaA (Allergopharma) Allergy Immunotherapies Sales Growth Rate (2012-2017)
Figure Merck KGaA (Allergopharma) Allergy Immunotherapies Sales Market Share in United States (2012-2017)
Figure Merck KGaA (Allergopharma) Allergy Immunotherapies Revenue Market Share in United States (2012-2017)
Table HAL Allergy Group (Netherlands) Basic Information List
Table HAL Allergy Group (Netherlands) Allergy Immunotherapies Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure HAL Allergy Group (Netherlands) Allergy Immunotherapies Sales Growth Rate (2012-2017)
Figure HAL Allergy Group (Netherlands) Allergy Immunotherapies Sales Market Share in United States (2012-2017)
Figure HAL Allergy Group (Netherlands) Allergy Immunotherapies Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Allergy Immunotherapies
Figure Manufacturing Process Analysis of Allergy Immunotherapies
Figure Allergy Immunotherapies Industrial Chain Analysis
Table Raw Materials Sources of Allergy Immunotherapies Major Players/Suppliers in 2016
Table Major Buyers of Allergy Immunotherapies
Table Distributors/Traders List
Figure United States Allergy Immunotherapies Sales Volume (Units) and Growth Rate Forecast (2017-2022)
Figure United States Allergy Immunotherapies Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Allergy Immunotherapies Price (K USD/Unit) Trend Forecast (2017-2022)
Table United States Allergy Immunotherapies Sales Volume (Units) Forecast by Type (2017-2022)
Figure United States Allergy Immunotherapies Sales Volume (Units) Forecast by Type (2017-2022)
Figure United States Allergy Immunotherapies Sales Volume (Units) Forecast by Type in 2022
Table United States Allergy Immunotherapies Sales Volume (Units) Forecast by Application (2017-2022)
Figure United States Allergy Immunotherapies Sales Volume (Units) Forecast by Application (2017-2022)
Figure United States Allergy Immunotherapies Sales Volume (Units) Forecast by Application in 2022
Table United States Allergy Immunotherapies Sales Volume (Units) Forecast by Region (2017-2022)
Table United States Allergy Immunotherapies Sales Volume Share Forecast by Region (2017-2022)
Figure United States Allergy Immunotherapies Sales Volume Share Forecast by Region (2017-2022)
Figure United States Allergy Immunotherapies Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources